IRIS
DE LUCA, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 887
NA - Nord America 671
AS - Asia 533
SA - Sud America 6
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.103
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 667
SE - Svezia 447
CN - Cina 250
SG - Singapore 221
IT - Italia 183
RU - Federazione Russa 117
FI - Finlandia 45
DE - Germania 29
PH - Filippine 20
NL - Olanda 11
IN - India 10
IE - Irlanda 9
FR - Francia 8
KR - Corea 8
UA - Ucraina 7
GB - Regno Unito 6
NO - Norvegia 6
TR - Turchia 6
AT - Austria 5
IR - Iran 5
MK - Macedonia 4
CA - Canada 3
PT - Portogallo 3
BR - Brasile 2
EU - Europa 2
HK - Hong Kong 2
HU - Ungheria 2
JP - Giappone 2
MY - Malesia 2
PE - Perù 2
TN - Tunisia 2
AL - Albania 1
AR - Argentina 1
BE - Belgio 1
DZ - Algeria 1
EC - Ecuador 1
ES - Italia 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
MX - Messico 1
PK - Pakistan 1
SI - Slovenia 1
TG - Togo 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 2.103
Salva come PNG Salva come JPEG
Città #
Singapore 141
Shanghai 119
Lawrence 99
Princeton 99
New York 74
Moscow 67
Ashburn 61
Boardman 52
Milan 48
Helsinki 42
Rome 15
Guangzhou 13
Los Angeles 11
Dublin 9
Makati City 9
Seattle 8
Seongnam-si 8
Shenzhen 8
Beijing 7
Ancona 6
Dallas 6
Oslo 6
Pune 6
Santa Clara 6
Buffalo 5
Howell 5
Quanzhou 5
Verona 5
Dronten 4
Florence 4
Istanbul 4
Mestrino 4
Quezon City 4
Vaprio d'Adda 4
Amadora 3
Angera 3
Cabanatuan City 3
Gallarate 3
Jiaxing 3
Lappeenranta 3
Nantong 3
Nuremberg 3
Osimo 3
Pisa 3
Skopje 3
Springfield 3
Taizhou 3
Vittoria 3
Wuxi 3
Angers 2
Ankara 2
Arezzo 2
Arnsberg 2
Castel Mella 2
Catania 2
Dalmine 2
Enschede 2
Foshan 2
Gatchina 2
General Trias 2
Honcho 2
Hyde Park 2
Kassel 2
Lima 2
Marana 2
Mykolayiv 2
New Delhi 2
Orani 2
Padova 2
Paris 2
Perm 2
Petaling Jaya 2
Pécs 2
San Mateo 2
Segrate 2
St Petersburg 2
Torre Del Greco 2
Vignola 2
Washington 2
West Jordan 2
Xi'an 2
York 2
Zhengzhou 2
Aci Catena 1
Amman 1
Amsterdam 1
Arcugnano 1
Athens 1
Atlanta 1
Balasore 1
Baoding 1
Borås 1
Brussels 1
Buenos Aires 1
Capaccio 1
Certaldo 1
Cesano Maderno 1
Chicago 1
Chongqing 1
Ciserano 1
Totale 1.094
Salva come PNG Salva come JPEG
Nome #
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 49
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 48
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 42
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 39
B cells in systemic sclerosis: A possible target for therapy 39
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli 33
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis 29
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 29
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis 28
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 28
Adult leukoencephalopathies with prominent infratentorial involvement can be caused by Erdheim-Chester disease 28
Arrhythmias in Myocarditis: State of the Art 28
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation 28
C3-glomerulopathy and MGUS: The skin beyond the kidney 26
Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case series 26
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 26
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 26
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 26
Does the impact of COVID-19 on patients with systemic sclerosis change over time? 25
Assessing the role of pentraxin-3 in Takayasu's arteritis. Comment on: Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up. Alibaz-Oner F. et al 25
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 23
Pruritus characteristics in a large Italian cohort of psoriatic patients 23
Advances in potential targeted therapies for Erdheim-Chester disease 23
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 23
Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: An open-label cohort study 23
A Novel Histiocytosis With Synovial and Skin Involvement 23
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 23
Spectrum of short-term inflammatory musculoskeletal manifestations after COVID-19 vaccine administration: a report of 66 cases 23
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 23
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 22
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 22
Drug retention rates of biological agents in adult onset Still's disease 22
Therapeutic strategies for virus-negative myocarditis: a comprehensive review 21
ASSOCIAZIONE TRA MALATTIA IGG4-CORRELATA E IMMUNOTERAPIA ALLERGENE-SPECIFICA. STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO. 21
Heart Involvement in Systemic Sclerosis: the Role of Magnetic Resonance Imaging 21
Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: The Role of Endomyocardial Biopsy 20
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use 20
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis 20
Systemic sclerosis myocarditis has unique clinical, histological and prognostic features: a comparative histological analysis 20
Immunosuppressive Therapy and Risk Stratification of Patients With Myocarditis Presenting With Ventricular Arrhythmias 20
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease 20
Anti-Ku syndrome with elevated CK: Association with myocardial involvement in systemic sclerosis 20
Nailfold capillaroscopy findings in patients with coronavirus disease 2019: Broadening the spectrum of COVID-19 microvascular involvement. 20
Cardiac immune-related adverse events: an immune-cardio-oncology puzzle 20
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 20
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 19
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 19
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 19
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 19
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 19
Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies 19
Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group 18
Cardiac magnetic resonance in systemic sclerosis patients with cardiac symptoms: do we really need it? 18
Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis 18
Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: A prospective cohort study 18
Measuring the T-cell down-regulation of TCR-zeta, ZAP-70 and CD28 in arthritis patients: An old tool for new biomarkers 18
Systemic syndromes of rheumatological interest with onset after COVID-19 vaccine administration: a report of 30 cases 18
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 17
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 17
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 17
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series 17
Unexpected acute lymphocytic virus-negative myocarditis in a patient with limited cutaneous systemic sclerosis: a case report 17
Hybrid FDG-PET/MR or FDG-PET/CT to Detect Disease Activity in Patients With Persisting Arrhythmias After Myocarditis 17
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 17
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 17
Association of anti-RNA polymerase III antibody with silicone breast implants rupture in a multicentre series of Italian patients with systemic sclerosis 17
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition 17
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience 17
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 17
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 16
Generalized morphea after COVID-19 vaccines: a case series 16
Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case series 16
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 16
QTc interval prolongation in Systemic Sclerosis: Correlations with clinical variables and arrhythmic risk 16
Low prevalence of arrhythmias in clinically stable COVID-19 patients 16
Telemedicine in myocarditis: Evolution of a mutidisciplinary “disease unit” at the time of COVID-19 pandemic 16
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study 16
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 16
Cardiac Safety of mRNA-based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis 16
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 15
Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition 15
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 15
Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease (Arthritis Research and Therapy (2019) 21 (54) DOI: 10.1186/s13075-019-1843-9) 15
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic 15
Patient-reported outcome instruments in clinical trials of systemic sclerosis 15
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 15
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 15
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 14
The fibrogenic chemokine CCL18 is associated with disease severity in Erdheim-Chester disease 14
MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPERINFLAMMATION 14
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 14
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 14
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 14
Troponin in Stable Ischemic Heart Disease and Diabetes 14
Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis 14
Improvements of vascular outcomes in systemic sclerosis: halfway through, but still far to go 14
Therapeutic strategies for primary heart involvement in systemic sclerosis 13
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review 13
Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients 13
Successful use of sirolimus in a patient with cardiac microangiopathy in primary antiphospholipid syndrome 13
Totale 2.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.151
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 0 0 0 0 0 0 1 0 15 1
2020/202148 3 0 5 10 0 12 8 3 1 0 4 2
2021/2022249 1 0 102 46 9 16 4 7 11 31 5 17
2022/2023784 250 176 55 4 16 97 40 72 35 11 15 13
2023/2024744 25 56 75 67 65 111 42 82 5 33 36 147
2024/2025560 224 41 102 104 89 0 0 0 0 0 0 0
Totale 2.424